Michelle H. Miyashiro, M.D.

8% more Medicare Part D claims than the average hematology & oncology physician in 2024

949 Medicare Part D claims for 230 beneficiaries, against an average of 877 among the 10,784 providers of this specialty who prescribed in Part D. Brand-name drugs were 18% of claims. 15 claims were for opioids.

Most prescribed

1. Tamoxifen Citrate164 claims
2. Anastrozole119 claims
3. Letrozole68 claims
4. Alendronate Sodium49 claims
5. Raloxifene Hcl38 claims
6. Kisqali34 claims

Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.

The practice group's MIPS final score for 2023 (Medicare payment program): 86.2 of 100

The Merit-based Incentive Payment System score is reported for the practice group, not for one clinician alone. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.

Source: CMS Quality Payment Program, MIPS performance year 2023, group reporting; category weights for 2023 (qpp.cms.gov).

One hospital affiliation

1. Straub Clinic And HospitalHonolulu, HI · Acute Care Hospitals4 of 5 stars

Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through); hospitals matched to CMS Hospital General Information (Care Compare) (data.cms.gov). Star ratings are CMS hospital ratings, not ratings of this provider.